Market Size (2018)
$10.05B
Vertical: HealthcareBase Year: 201813 Sections
Market Size (2018)
$10.05B
Projected (2025)
$23.54B
CAGR (2016–2025)
12.7%
Key Players
10+
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Aesthetic procedures are the treatment done for the improvement of cosmetic appearance. Various aesthetic techniques are available in the market, which is effectively used for liposuction, hair removal, acne treatment, and others. Medical aesthetics are concerned with the use of various aesthetic products for medical purposes and to improve the overall appearance of the patient.
Key Contributing Factors
There are numerous factors that contribute to the growth of the global medical aesthetics market. The key factors are mentioned below in brief.
High Demand for Liposuction, Hair Transplantation, and the Rising Obese and Geriatric Population
According to the American Society for Aesthetic Plastic Surgery, 414,335 liposuction procedures were performed in the US in 2016.
Increasing Expenditure On Cosmetic and Aesthetic Procedures
According to the Cosmetic Physicians College of Australia in 2015, the Australians spent approximately USD 890 million on minimally invasive or non-invasive cosmetic procedures, exhibiting an increase of 5% as compared to 2014. Moreover, according to the International Trade Administration, in 2014, the per capita cosmetic expenditure in Japan was around USD 174.
Increasing Incidence of Skin Diseases
According to a study published in the Journal of Dermatological Case Reports in 2015, actinic keratosis is common in fair-skinned individuals when exposed to adequate sunlight. Moreover, the study reported that in Australia, approximately 40% to 50% of the Caucasian population, aged 40 years or more, develops actinic keratosis.
The Medical Aes Market market is projected to grow at a CAGR of 12.7% from 2016 to 2025.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMedical Aes Market
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
Medical aesthetics refer to specialties which focus on improving cosmetic appearance by treating conditions such as wrinkles, scars, cellulite, unwanted hair, and moles, amongst others. The current trend is use of non-invasive procedures to treat cosmetic imperfections. Increasing awareness about the benefits of combination therapies in aesthetic medicines is leading to its widespread acceptance among the population of all age groups. The global medical aesthetics market has been bifurcated into product, end user, and region.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2017
Forecast Period
2019 – 2025
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2025)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe global medical aesthetics market is characterized by the presence of global, regional, and local vendors. The market is highly competitive with all players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products, to survive and succeed in an intensely competitive and growing market environment.
The growth of market vendors is dependent on market conditions, government support, and industry development. Thus, vendors should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although international players are dominating the market, regional, and foreign players with small market shares also have a presence. The international players may strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that improvement of the global economic scenario combined with efforts to enhance infrastructure in emerging nations, is fueling the market growth, thereby making it an ideal time for new products and to increase the market share. Vendors with better technical and financial resources could develop innovative products. Therefore, vendors must develop new technologies and stay well-informed of emerging technologies that could affect the continuing competitiveness of their treatment lines in the market.
Some key players operating in this market are Allergan, Merz Pharma GmbH & Co. KGaA, Hologic, Inc., Syneron Medical Ltd, and Cutera.
Allergan is a global pharmaceutical company that holds 42.9% in the global medical aesthetics market. The company was established in 1948 and headquartered in Dublin, Ireland. Allergan has a wind range of products which provides effective treatment for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology, and anti-infective therapeutic categories.
Merz Pharma GmbH & Co. KGaA is a second-largest player in the market with a 6.4% market share in the global medical aesthetics market. The company was established in 1953 and headquartered in Frankfurt,Germany, and is a global aesthetic and neurotoxin company which has its research and development capabilities. The company operates in fields such as neurology, OTC medicine, dietary supplements, and skincare products. Furthermore, in August 2016, Merz acquired the aesthetics medical device company on light sciences. By this acquisition, the company established itself in the field of on-light science innovation technology and aimed to meet the needs of aesthetic practices that focus on energy-based devices.
Syneron Medical Ltd holds 3.6% market share in the global medical aesthetics market and mainly focuses on matured markets for revenue generation. The company offers medical devices for aesthetic procedures. Hologic Inc. (3.4%) and Cutera (1.6%) are also considered significant players in the medical aesthetics market.
Other companies include Lumenis, Galderma SA, Bausch Health, Anika Therapeutics Inc., and Alma Lasers.
Michael Porter’s five forces model gives a framework that models the global medical aesthetics market, which is influenced by five forces. The strategic business managers, trying to create an edge over competing firms in the global medical aesthetics market can utilize this model to comprehend better the industry connection in which the firm operates. The components of each of the forces and the degree or impact of each component in the context of the global medical aesthetics industry have been broken down and analyzed below.
Bargaining Power of Suppliers
The bargaining power of suppliers in the medical aesthetics market is moderate. In the global aesthetics industry, suppliers are raw materials manufacturers and Original Intermediate Equipment Manufacturers (OEM). The number of suppliers in the market is sufficiently high to provide plenty of options to the manufacturers for material sourcing which is required for the production of the various products, thus leaving suppliers with moderate bargaining power. Another factor affecting the bargaining power of suppliers is the supplier switching cost for buyers owing to the presence of a moderate number of raw material suppliers in the market. On the other hand, only a moderate number of viable raw material substitutes are available, which further boosts the bargaining power of suppliers in the market. Switching cost of these suppliers is high as the suppliers tend to enter long-term associations with the manufacturers.
Bargaining Power of Buyers
The bargaining power of buyers is low to moderate in the medical aesthetics market. Hospitals and cosmetic surgery clinics are the primary buyers in the market. The presence of buyers in the market is growing due to the increasing awareness of the benefits of aesthetic procedures, along with the rising number of various aesthetics procedures. The buyers of aesthetic products are moderately inclined towards branded products manufactured by renowned companies. Moreover, the buyers can exert moderate pressure on the manufacturers as there are many manufacturers that are present in the market. Also, some buyers are price-sensitive and might prefer less technologically advanced non-invasive procedures, thereby moderately affecting their bargaining power in the market.
Threat of New Entrants
The threat of new entrants is moderate in the global medical aesthetics market due to the development of the potential market. Any aesthetic manufacturing company trying to enter the market is required to accept and abide by the mandatory regulatory standards. This market is also characterized by a reasonable degree of brand loyalty, where establishing a brand name is difficult for new entrants. The rising awareness regarding the aesthetic procedures and its benefits among the patients pushes the currently established and other manufacturers to focus more toward the adoption of innovative technologies. There is a stronghold of the big companies in this market, which can make the entry of the new players challenging. Thus, the threat of new entrants in the market is moderate.
Threat of Substitutes
The threat of substitutes in the global medical aesthetics market is low to moderate. Substitutes pose a low to moderate threat in the global medical aesthetics market due to the low availability of alternative therapies present in the market. However, quality and trust issue for the dermal fillers and devices provided by the new players, and excellent service provided by the existing players may restrict the threat by the substitutes to an extent. Also, the low-medium degree of switching cost may minimize the threat of substitutes.
Intensity of Rivalry
The degree of competition in the global medical aesthetics market is moderate to high. The moderate degree of product differentiation among existing players increases the intensity of rivalry in the market. Companies involved in the medical aesthetics market are trying to develop cost-effective products to make product differentiation more affordable. To overcome the competition, players are engaged in developing a process to lower their manufacturing cost. Moreover, the players are also developing advanced techniques for differentiating their product from their rivals.
Market estimates by geography (2025)
InsightAmericas leads with $10.45B by 2025, while Asia Pacific is projected to grow fastest at a 13.1% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2025 | CAGR | SHARE |
|---|---|---|---|---|---|
| Europe | $2.25B | $3.98B | $6.43B | 12.4% | 24% |
| Asia Pacific | $1.56B | $2.86B | $4.72B | 13.1% | 18% |
| Middle East and Africa | $1.56B | $2.86B | $4.72B | 13.1% | 18% |
| Americas | $3.51B | $6.37B | $10.45B | 12.9% | 40% |
| Total | $8.88B | $16.07B | $26.32B | 12.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$23.54B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Facial Aesthetic | $7.12B | 12.5% | 30% |
| Body Contouring Devices | $4.68B | 13.2% | 20% |
| Cosmetic Implants | $3.62B | 13.0% | 15% |
| Hair Removal Devices | $2.80B | 12.6% | 12% |
| Skin Aesthetic Devices | $2.32B | 12.6% | 10% |
| Product_Others | $1.97B | 12.4% | 8% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Medical Aes Market covering market dynamics, competitive landscape, and strategic outlook.
The Medical Aes Market market is projected to reach $23.54B by 2025, growing at 12.7% CAGR. The Facial Aesthetic segment holds the largest share.
The global medical aesthetics market is mainly driven by the high demand for liposuction, hair transplantation, and increasing acceptance of facial aesthetics in the aesthetic industry. The growing expenditure on cosmetic surgeries coupled with technological advancements, rising obese and geriatric population, and the prevalence of skin diseases are expected to drive the market growth. High procedural costs, sophistication, and training associated with aesthetic procedures, and side-effects related to cosmetic procedures may slow down the growth of the market during the forecast period. Rising demand for minimally invasive procedures provides an opportunity for the growth of the market.
The growing obese and geriatric population across the globe is leading to an increased demand for aesthetic procedures such as liposuction, hair transplantation, and others. Moreover, the growing demand for beauty treatments and other anti-aging-related cosmetic procedures are accelerating the growth of the global medical aesthetics market. The rising need to appear younger and visible positive effects of these treatments are increasing the popularity of aesthetic procedures across the globe.
In 2016, according to the International Society of Aesthetic Plastic Surgery, an estimated 18,447 liposuction procedures were performed in Taipei, accounting for 1.3% of the total surgical liposuction procedures across the globe. Moreover, it was determined that India stood third in liposuction procedures, representing 5.0% of the total liposuction procedures performed in the world. According to the American Society for Aesthetic Plastic Surgery, 414,335 liposuction procedures were performed in the US in 2016.
According to the Australian Institute of Health and Welfare from 2014 to 2015, approximately two-thirds, i.e., 63% of the Australian population aged 18 and above were estimated to be overweight or obese, thus increasing the number of individuals with hair fall problem as obesity affects hair fall.
The number of hair restoration patients in Asia was approximately 427,709 in 2014, according to the International Society of Hair Restoration Surgery.
As per the Hair Society, around 40% hair loss rate is estimated in men by the age of 35, which is expected to grow and reach up to 70% in men by the age of 80 years.On the other hand, women of around 60 years of age have a hair loss rate of approximately 80%. Moreover, the Economic and Social Commission for Asia-Pacific estimated that in 2016, about 12.4% of the population within the region was aged 60 or more and is expected to reach 1.3 billion by 2050. This increasing obese population, in turn, is expected to increase the number of patients suffering from hair fall and hence increase the number of hair transplantation procedures.
Furthermore, there is a trend of getting tattoos among people in developing economies such as India, China, and Japan. This increases the probability of tattoo removal procedures, enhancing the growth of the medical aesthetics market in the region. With the high demand for procedures such as liposuction and hair transplantation by the growing obese and geriatric population, the global market for medical aesthetics is estimated to grow substantially during the forecast period.
The demand for minimally invasive procedures is increasing, and non-surgical procedures are being performed in hospital-based outpatient clinics. Moreover, the per capita incomes and healthcare expenditure in economies such as India is rising, which is likely to provide a significant boost to the market growth during the forecast period.
The population in developing economies is focusing on minimally invasive procedures to treat a variety of medical and aesthetic imperfections such as scars, wrinkles, skin discoloration, unwanted spots, excess fat, and spider veins.
According to the International Society of Aesthetic Plastic Surgery in 2016, approximately 43,047 and 15,764 non-surgical procedures for botulinum toxin and hair removal were performed in Australia.
The Asian-Pacific Islander population, according to the American Society of Plastic Surgeons, accounted for approximately 5.0%, in 2016, of all the reported cases of microdermabrasion.
In 2016, the International Society of Aesthetic Plastic Surgery stated that 120,640 non-surgical photo rejuvenation procedures were performed in Japan. Increasing demands for minimally invasive aesthetic procedures are providing growth opportunities, which can be attributed to the expansion of the market.
Despite the growing adoption of aesthetics, the high cost associated with the aesthetics procedure is hampering the growth of the market. The cost of breast augmentation is high. In India, the cost of breast augmentation is estimated to be around USD 1,200 to USD 2,200, depending upon the type of augmentation.
Moreover, within the region, liposuction can cost from USD 550 to USD 2,600. The average estimated cost of laser slimming treatment in Japan is estimated to be in the range of USD 2520 to USD 3025. The presence of middle and low-income countries within the Asia-Pacific and the Middle Eastern and African regions, may not support the growth of the market during the forecast period.
As the trend towards globalization continues, more price transparency is to be expected, along with the increasing professionalism of purchasing behavior. The costs involved in the aesthetic industry majorly affect the suppliers and manufacturers in deciding the pricing for their products in a certain market. In certain countries, aesthetic procedures have a fixed price schedule, which in turn affects the pricing strategy of manufacturers and supply chain management who have to manage low costs and also not compromise on the quality of materials produced. It has been noted that many manufacturers in this market are manufacturing products in various quality grades which are reflected in their final price for these products.
While these companies may have a base, medium, or high price and quality levels, these price ranges cannot be easily identified as the product mix varies from country to country. Also, supplier incentive and demand encouragement can play a significant role in deciding the pricing of this aesthetic procedure. In a fierce competing market, the aesthetic manufacturing company will have to strategize its pricing levels as per the quality and affordability of consumers to increase their market share.
Investment opportunities highlight the growth of the industry, which depends on various factors such as patents and approvals, geriatric and obese population, the growth of the aesthetics industry, and risk factors. Patents safeguard the key design elements of a new product while maintaining product differentiation and uniqueness. Rapid innovation in the aesthetic industry benefits both the manufacturing company as well as the investors, fetching great profits for both. Therefore, innovations would provide investment opportunities in the future.
The geriatric and obese population is another factor contributing to the growth of the medical aesthetics market, further encouraging investments. Many countries are experiencing a rise in the geriatric and obese population. Therefore, the global medical aesthetics market is likely to show extensive growth due to an increase in the demand for aesthetics in the presence of rising cosmetic expenditures.
There are extensive growth opportunities in the aesthetics industry, which is governed by innovative and technologically advanced products. In this case, the company’s research and development plays an important role to determine the potential of new products in the market.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 105 companies operating in the Medical Aes Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
Cutera
Company Headquarters: California, US Founded: 1998 Workforce: ~540 Company Working: Cutera is a global manufacturer and supplier of laser and energy-based aesthetic systems to practitioners all over the world. The Company creates, develops, manufactures, distributes, and markets light and energy-based product platforms for physicians and other qualified practitioners to employ to provide safe and effective cosmetic treatments to its consumers. Furthermore, the Company sells third party-made skincare items. The Company's continuous research and development activities are primarily focused on the creation of new products as well as the improvement and enhancement of the Company's existing product line.
Anika Therapeutics Inc.
Company Headquarters: Massachusetts, US Founded: 1992 Workforce: ~133 Company Working: Anika Therapeutics is an orthopedic and regenerative medicines company. Its offers products based on hyaluronic acid, biocompatible polymer, and natural chemical. In the US, the company owns 19 patents and internationally 187 patents. In 2018, the company’s top five customers account 86% of the revenue, e.g., Mitek, a part of Johnson & Johnson medical device company and the global leader in orthopedic sports medicine accounted 73% of the company sales revenue. The company primarily depends on a small number of large customers, particularly Mitek, for the majority of its sales revenues. The company markets and distribute its products in the US, Italy, and European countries, among others.
Allergan
Company Headquarters: Dublin, Ireland Founded: 2013 Workforce: ~16,900 Company Working: Allergan is a leading global pharmaceutical company. The company is engaged in the manufacturing and commercialization of hyaluronic acid for medical products, devices, biologics, and surgical products for patients across the world. It operates through three business segments, namely US Specialized Therapeutics, US General Medicine, and International. The company sells its products primarily to the retailers and distributors including food store chains and national retail drug. The prime customers are hospitals, clinics, and government agencies as well as managed healthcare providers, such as health maintenance organizations and other institutions. The company has operations in 100 countries. The US and Canada account for around 10% of the company’s revenue. The three prominent customers of the company are McKesson Corporation, which accounted for around 25% of the sales revenue; Cardinal Health, Inc with 23%; and AmerisourceBergen Corporation with 22% in 2018. In addition, the company has development and manufacturing centers of raw materials, intermediate ingredients, and active pharmaceutical ingredients. Its manufacturing plants are located in Ireland, the US, Brazil, Belgium, France, and Costa Rica.
Lumenis
Company Headquarters: Yokneam, Israel Founded: 1991 Workforce: ~1137 Company Working: Lumenis develops and commercializes medical systems for use in minimally invasive procedures worldwide. It was formerly known as ESC Medical Systems Ltd and changed its name to Lumenis in September 2001. It operates through three segments, namely surgical, ophthalmic, and aesthetic. The aesthetics segment offers products related to hair removal, body, skin treatment, pigmentation, scar treatment, and tattoo removal. Moreover, the company markets its products through a network of third-party distributors, direct sales force, and independent distributors.
Syneron Medical Ltd
Syneron Medical Ltd. also known as Syneron Candela is the global player in the aesthetic medical devices and has distribution network worldwide. The company sells it’s products under three brand names Syneron, Candela and CoolTouch. The products are marketed, serviced and supported in 86 countries worldwide. The offices are present in North America, France, Germany, Italy, U.K, Australia, China, Japan and Hong Kong. The company was founded in 2000 and is headquartered in Yokneam Lllit, Israel. Company has various subsidiaries under its name. The company is recommended number 1 for the energy device brand by U.S dermatologist. The Syneron Candela is highly recognized brand for the hair removal, facial rejuvenation, skin tightening & vascular treatments.
Galderma Laboratories
Established in 1981 and headquarters in Lausanne, Switzerland. Galderma is one of the big names of the pharmaceutical industry in dermatology, over the past three decades galderma key area of focus is to provide innovative solutions in the field of dermatology, which consists of acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and other various fields in skin care. Currently Galderma is a global leader in dermatology and has strategic partnerships with brands like Soolantra, Tri-Luma, Loceryl, BenzacEpiduo, Oracea, Differin, Mirvaso, Cetaphil, Excipial, Daylong, Restylane, Emervel and many other brands. Presently galderma is operating in over 80+ countries, providing patients with skin care needs and has an employee work force of over 6000 employees. The company has worldwide network of distributers and 34 wholly-owned affiliates.
8 interactive charts drawn from the Medical Aes Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Medical Aes Market Middle-East and Africa Of Middle East And Africa
Global Medical Aes Market Australia, China, India, Japan, South Korea and Rest Of Asia Pacific By Country
Global Medical Aes Market Germany, Spain, France, United Kingdom, Ireland, Italy and Rest Of Europe By Country
Global Medical Aes Market By Region
Medical Aes Market Middle East And Africa
Medical Aes Market Asia Pacific By Country
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence